Legal Opinion
In Re Glaxo '845 Patent Litigation
District Court, S.D. New York
Decided September 28, 2006No. 03Civ.10260(LTS)(FM)Published
This document relates to: All Actions
1Opinion of the Court
Memorandum Order
SWAIN, District Judge.
Plaintiff Glaxo Group Ltd. d/b/a GlaxoSmithKline (“GSK”) brings this partial summary judgment motion directed to the obviousness-type double patenting affirmative defenses, and related counterclaims for declaratory relief, asserted by defendants Dr. Reddy’s Laboratories, Ltd. And Dr. Reddy’s Laboratories, Inc. (Collectively, “DRL”) and Cobalt Pharmaceuticals, Inc. (“Cobalt” and, together with DRL, “Defendants”) in this patent litigation arising from Defendants’ Abbreviated New Drug Application for a generic version of GSK’s highly successful migraine drug…
2Cases cited9 opinions
- Nicholas v. Perricone, M.D. v. Medicis Pharmaceutical Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2005
- In Re Paolo LongiCourt of Appeals for the Federal Circuit · 1985
- In Re Robert Goodman, Vic C. Knauf, Catherine M. Houch and Luca ComaiCourt of Appeals for the Federal Circuit · 1993
- Gerber Garment Technology, Inc. v. Lectra Systems, Inc. And Lectra Systems, S.A.Court of Appeals for the Federal Circuit · 1990
- Eli Lilly And Company v. Barr Laboratories, Inc.Court of Appeals for the Federal Circuit · 2001
4 more not listed; retrieve them via the Exa API.